Article Menu

Academic Editors

Engi Abd El Hady Algharably

Ursula Gundert-Remy
Subscribe SciFeed
Recommended Articles
Related Info Links
- PubMed/Medline
- Google Scholar
More by Authors Links

/ajax/scifeed/subscribe

Article Views

Citations -

Altmetric Share Help Cite Discuss in SciProfiles

Need Help?

Support

Find support for a specific problem in the support section of our website.

Get Support

Feedback

Please let us know what you think of our products and services.

Give Feedback

Information

Visit our dedicated information section to learn more about MDPI.

Get Information

Open AccessArticle

Article Versions Notes

Pharmaceuticals 2025, 18(7), 996; https://doi.org/10.3390/ph18070996

Action	Date	Notes	Link
article xml file uploaded	2 July 2025 12:53 CEST	Original file	-
article xml uploaded.	2 July 2025 12:53 CEST	Update	-
article pdf uploaded.	2 July 2025 12:53 CEST	Version of Record	https://www.mdpi.com/1424-8247/18/7/996/pdf-vor
article supplementary file uploaded.	2 July 2025 12:53 CEST	-	https://www.mdpi.com/1424-8247/18/7/996#supplementary
article html file updated	2 July 2025 12:55 CEST	Original file	-
article xml file uploaded	3 July 2025 04:38 CEST	Update	-
article xml uploaded.	3 July 2025 04:38 CEST	Update	https://www.mdpi.com/1424-8247/18/7/996/xml
article pdf uploaded.	3 July 2025 04:39 CEST	Updated version of record	https://www.mdpi.com/1424-8247/18/7/996/pdf
article html file updated	3 July 2025 04:41 CEST	Update	https://www.mdpi.com/1424-8247/18/7/996/html

Cite

Export citation file: BibTeX | EndNote | RIS

MDPI and ACS Style

Pérez-Gómez, N.; Sanz-Solas, A.; Cuevas, B.; Cuevas, M.V.; Alonso-Madrigal, C.; Loscertales, J.; Álvarez-Nuño, R.; García, C.; Zubiaur, P.; Villapalos-García, G.; et al. Pharmacogenetic Biomarkers of Ibrutinib Response and Toxicity in Chronic Lymphocytic Leukemia: Insights from an Observational Study. Pharmaceuticals 2025, 18, 996. https://doi.org/10.3390/ph18070996

AMA Style

Pérez-Gómez N, Sanz-Solas A, Cuevas B, Cuevas MV, Alonso-Madrigal C, Loscertales J, Álvarez-Nuño R, García C, Zubiaur P, Villapalos-García G, et al. Pharmacogenetic Biomarkers of Ibrutinib Response and Toxicity in Chronic Lymphocytic Leukemia: Insights from an Observational Study. Pharmaceuticals. 2025; 18(7):996. https://doi.org/10.3390/ph18070996

Chicago/Turabian Style

Pérez-Gómez, Noelia, Antonio Sanz-Solas, Beatriz Cuevas, María Victoria Cuevas, Cristina Alonso-Madrigal, Javier Loscertales, Rodolfo Álvarez-Nuño, Covadonga García, Pablo Zubiaur, Gonzalo Villapalos-García, and et al. 2025. "Pharmacogenetic Biomarkers of Ibrutinib Response and Toxicity in Chronic Lymphocytic Leukemia: Insights from an Observational Study" Pharmaceuticals 18, no. 7: 996. https://doi.org/10.3390/ph18070996

APA Style

Pérez-Gómez, N., Sanz-Solas, A., Cuevas, B., Cuevas, M. V., Alonso-Madrigal, C., Loscertales, J., Álvarez-Nuño, R., García, C., Zubiaur, P., Villapalos-García, G., Parra-Garcés, R. M., Mejía-Abril, G., Alcaraz, R., Vinuesa, R., Díaz-Gálvez, F. J., González-Oter, M., García-Sancha, N., Azibeiro-Melchor, R., González-López, T. J., ... Saiz-Rodríguez, M. (2025). Pharmacogenetic Biomarkers of Ibrutinib Response and Toxicity in Chronic Lymphocytic Leukemia: Insights from an Observational Study. Pharmaceuticals, 18(7), 996. https://doi.org/10.3390/ph18070996

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Article Access Statistics

For more information on the journal statistics, click here.

Multiple requests from the same IP address are counted as one view.

Article Menu

Article Versions Notes

Further Information

Guidelines

MDPI Initiatives

Follow MDPI